False. If two Phase 3 ABSSSI trials cost $30M, why
Post# of 72430
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
Let's say P matches Otezla and for some crazy reasons no BP is interested so Leo is forced to advance it alone. I'll also assume one Phase 3 cost $15M (maximum) and the SP is $2 (minimum) after positive result is announced. So it'll take 7.5M shares (5.7% dilution) from the $42.8M shelf registration. Problems?
Dilutions are part of the game and it takes money to make money. So what was your concern again?
Quote:
Either of these would be north of $30M IMO.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)